-1.png?width=300&height=58&name=Proscia%20(11)-1.png "Proscia")
European Congress of Pathology 2025
The AI-Driven Future of Pathology Starts Now
Visit Proscia in Booth 46 at ECP 2025 in Vienna, Austria, and discover why a global network of diagnostic laboratories and 16 of the top 20 pharma companies use Concentriq®—our enterprise pathology platform built for AI-driven pathology from discovery to diagnosis.
What to Expect: Sessions and Demos
Join us throughout the congress for expert-led presentations and discussions on the future of diagnostic innovation.
Agilent Symposium
September 7, 2025 | 7:30-8:30PM | Room 1.85-86
Digital Pathology and AI 2.0: Truly Taking Usability, Interoperability and AI-Enabled Reporting to the Next Level. Learnings From Real-World Implementation
Dr. Bilal Ahmad, Spectrum Healthcare Partners
The session explores how Digital Pathology 2.0 should break adoption barriers in routine practice. Dr. Ahmad will share implementation learnings from live deployments, including seamless scanning‐to‐report-generation pipelines, AI‐augmented quality control, and vendor‐neutral integration strategies critical for sustainable adoption.
In-Booth Presentations
We’ll be hosting a series of expert talks and live demos in our booth (#46) throughout ECP 2025.
Partner
Session Information
September 7, 2025 | 10:00-10:15AM
Streamlined MSI testing with AI
Julien Wallemacq, Market Development Director
September 7, 2025 | 2:30-2:45PM
Opportunities for transforming into Digital Pathology, leveraging cloud-based solutions
Dr. Yin Cai, EMEA Healthcare Technical Business Development Manager - Precision Medicine
September 8 2025 | 10:00-10:15AM
Real World Benefits from AI-driven Clinical Decision Support.
Assaf Peled, Director of Product Management
September 8 2025 | 2:30-2:45PM
Clinical Utility of Mindpeak’s IHC Foundation Model for Digital Pathology Worldwide: HER2 Ultralow Insights from 2,000+ Patients
Dr. Patrick Frey, Head of Precision Medicine
September 9, 2025 | 10:00-10:15AM
The Future of Reporting in Pathology: AI-Driven and Seamlessly Integrated
Alexander Albert, VP Sales & BD
September 9, 2025 | 2:30-2:45PM
Pathology’s Next Step: Making AI Work in Practice
Dr. Dirk Vossen, Chief Diagnostics Officer
Let's Meet at ECP
We’re rewiring pathology for precision medicine. This is your opportunity to see how—and why it matters for modern laboratories like yours.
- KLAS A+* grade for customer support
- Industry-leading customer experience: 100%* of customers surveyed by KLAS said they would buy again
- 32,000 patients diagnosed daily and 8,000,000 cases processed annually on Concentriq**
- Concentriq is engineered for enterprise-grade performance, security, and flexibility, used daily by over 12,000 scientists and pathologists.
- An intuitive user experience and interoperability with SMART Reporting, DICOM, LIMS, PACS.
- Integrations with 100+ LIS instances ensures seamless adoption, fewer silos, and faster workflows.
- Access to 120+ AI applications in our Precision Medicine AI Portfolio
*Customers surveyed by KLAS Research in the Emerging Company Spotlight report: Proscia Concentriq, Digital Pathology Software Aimed at Overcoming Diagnostic Challenges & Improving Lab Efficiency, gave the company an ‘A+’ grade for the quality of its phone and web support and 100% said they would buy again.
**Based on current projections
Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked under the EU IVDR for primary diagnosis .Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Research Use Only. Not for use in diagnostic procedures. Proscia’s AI applications are available for research use only.